Alzamend Neuro (ALZN) Net Income towards Common Stockholders (2020 - 2026)
Alzamend Neuro (ALZN) posted Net Income towards Common Stockholders of $3 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$2.7 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Net Income towards Common Stockholders at Alzamend Neuro was -$3.07 million; for FY2026 (ended Apr 30, 2026), it was -$8.77 million.
- In prior fiscal years, Alzamend Neuro's Net Income towards Common Stockholders was -$5.11 million in FY2025, -$9.95 million in FY2024, -$14.88 million in FY2023 and -$12.36 million in FY2022.
- The fiscal Q1 2027 figure stands as the highest quarterly Net Income towards Common Stockholders in data going back to fiscal Q1 2021.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior fiscal quarters was -$2.87 million (Q4 2026), -$2.2 million (Q3 2026) and -$1 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Alzamend Neuro | 6.61 Mn | 6.61 Mn | - | 3.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 3.00 Mn |
| Apr 30, 2026 | -2.87 Mn |
| Jan 31, 2026 | -2.20 Mn |
| Oct 31, 2025 | -1.00 Mn |
| Jul 31, 2025 | -2.70 Mn |
| Apr 30, 2025 | -1.64 Mn |
| Jan 31, 2025 | -1.07 Mn |
| Oct 31, 2024 | -1.42 Mn |
| Jul 31, 2024 | -974,411.00 |
| Apr 30, 2024 | -851,529.00 |
| Jan 31, 2024 | -2.66 Mn |
| Oct 31, 2023 | -2.91 Mn |
| Jul 31, 2023 | -3.53 Mn |
| Apr 30, 2023 | -3.31 Mn |
| Jan 31, 2023 | -5.43 Mn |
| Oct 31, 2022 | -3.11 Mn |
| Jul 31, 2022 | -3.04 Mn |
| Apr 30, 2022 | -3.87 Mn |
| Jan 31, 2022 | -2.57 Mn |
| Oct 31, 2021 | -3.60 Mn |
API Access
Alzamend Neuro Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();